Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Blandini

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Functional Neurology|May 9, 2002
The role of the subthalamic nucleus in the pathophysiology of Parkinson's diseaseF Blandini
Analytical Biochemistry|September 1, 1995
Assay of [3H]dihydrorotenone binding to complex I in intact human plateletsF Blandini, J T Greenamyre
Drugs of Today (Barcelona, Spain : 1998)|September 16, 2003
Protective and symptomatic strategies for therapy of Parkinson's diseaseF Blandini, J T Greenamyre
Brain Research|January 9, 1995
Effect of subthalamic nucleus lesion on mitochondrial enzyme activity in rat basal gangliaF Blandini, J T Greenamyre
Fundamental & Clinical Pharmacology|April 2, 1998
Prospects of glutamate antagonists in the therapy of Parkinson's diseaseF Blandini, J T Greenamyre
Functional Neurology|February 24, 2001
Mapping neuronal activity of the basal ganglia in experimental models of Parkinson's disease: contributions of the [14C]2-deoxyglucose methodF Orzi, F Fornai, F Blandini
Annals of Neurology|April 20, 2001
Subthalamic infusion of an NMDA antagonist prevents basal ganglia metabolic changes and nigral degeneration in a rodent model of Parkinson's diseaseF Blandini, G Nappi, J T Greenamyre
Movement Disorders : Official Journal of the Movement Disorder Society|February 6, 1998
Quantitative study of mitochondrial complex I in platelets of parkinsonian patientsF Blandini, G Nappi, J T Greenamyre
Functional Neurology|January 1, 1996
The role of glutamate in the pathophysiology of Parkinson's diseaseF Blandini, J T Greenamyre, G Nappi
Functional Neurology|January 24, 1998
Systemic administration of ephedrine induces Fos protein expression in caudate putamen and subthalamic nucleus of ratsF Blandini, S A Joseph, C Tassorelli
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Functional Neurology|May 9, 2002
The role of the subthalamic nucleus in the pathophysiology of Parkinson's diseaseF Blandini
Analytical Biochemistry|September 1, 1995
Assay of [3H]dihydrorotenone binding to complex I in intact human plateletsF Blandini, J T Greenamyre
Drugs of Today (Barcelona, Spain : 1998)|September 16, 2003
Protective and symptomatic strategies for therapy of Parkinson's diseaseF Blandini, J T Greenamyre
Brain Research|January 9, 1995
Effect of subthalamic nucleus lesion on mitochondrial enzyme activity in rat basal gangliaF Blandini, J T Greenamyre
Fundamental & Clinical Pharmacology|April 2, 1998
Prospects of glutamate antagonists in the therapy of Parkinson's diseaseF Blandini, J T Greenamyre
Functional Neurology|February 24, 2001
Mapping neuronal activity of the basal ganglia in experimental models of Parkinson's disease: contributions of the [14C]2-deoxyglucose methodF Orzi, F Fornai, F Blandini
Annals of Neurology|April 20, 2001
Subthalamic infusion of an NMDA antagonist prevents basal ganglia metabolic changes and nigral degeneration in a rodent model of Parkinson's diseaseF Blandini, G Nappi, J T Greenamyre
Movement Disorders : Official Journal of the Movement Disorder Society|February 6, 1998
Quantitative study of mitochondrial complex I in platelets of parkinsonian patientsF Blandini, G Nappi, J T Greenamyre
Functional Neurology|January 1, 1996
The role of glutamate in the pathophysiology of Parkinson's diseaseF Blandini, J T Greenamyre, G Nappi
Functional Neurology|January 24, 1998
Systemic administration of ephedrine induces Fos protein expression in caudate putamen and subthalamic nucleus of ratsF Blandini, S A Joseph, C Tassorelli
Pageof 6